Table 1 HCV testing in the Tromsø 7 Study (n = 20,946)
From: Screening for hepatitis C in a general adult population in a low-prevalence area: the Tromsø study
Women | Men | Total | ||||
|---|---|---|---|---|---|---|
Age (years) | Invited | Tested (%) | Invited | Tested (%) | Invited | Tested (%) |
40–49 | 5195 | 3360 (64.7%) | 5562 | 3033 (54.5%) | 10,757 | 6393 (59.4%) |
50–59 | 4534 | 3230 (71.2%) | 4327 | 2767 (63.9%) | 8861 | 5997 (67.7%) |
60–69 | 3586 | 2652 (74.0%) | 3543 | 2487 (70.2%) | 7129 | 5139 (72.1%) |
70–79 | 2001 | 1352 (67.6%) | 1897 | 1310 (69.1%) | 3898 | 2662 (68.3%) |
80–89 | 981 | 386 (39.3%) | 639 | 322 (50.4%) | 1620 | 708 (43.7%) |
90–104 | 242 | 24 (9.9%) | 84 | 23 (27.4%) | 326 | 47 (14.4%) |
Total | 16,539 | 11,004 (66.5%) | 16,052 | 9942 (61.9%) | 32,591 | 20,946 (64.3%) |